Stacey Frisk is named as a lobbyist on federal disclosure filings for 1 client through Rare Disease Company Coalition. The most recent filing naming them posted in April 2026. Issues reported include Pharmacy, Science/Technology, Trade (domestic/foreign) and Budget/Appropriations.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| RARE DISEASE COMPANY COALITION | RARE DISEASE COMPANY COALITION | Q1 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Stacey Frisk. See the Capitol Clarity rankings and method.